Is your check engine light on? Before you panic over a massive repair bill, discover the five most common faults triggering ...
MouseKey is a lightweight Windows app that turns any mouse into a productivity powerhouse by letting you remap buttons with up to six different actions per button. It works with virtually any mouse, ...
This Mazda hybrid shares its powertrain with the RAV4 Hybrid and skips the dealer markup drama, making it a smarter buy for ...
In oncology, the manipulation of metabolic processes within tumors has surfaced as a pivotal strategy for influencing cancer progression and therapy resistance. Tumor cells often undergo metabolic ...
Andy Lupini, distinguished R&D staff member of ORNL’s Electron Microscopy and Microanalysis Group, and Kevin Roccapriore — on entrepreneurial leave from ORNL’s Data NanoAnalytics Group to launch the ...
Abstract: Accurate and timely air quality prediction is crucial for cities and individuals to effectively take necessary precautions against potential air pollution. Existing studies typically rely on ...
A novel combination of mRNA technology and immune modulation may offer a new strategy for treating allergic diseases, according to new research demonstrating enhanced immune tolerance and reduced ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...
Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
A highly anticipated gene therapy human trial is now testing whether scientists can make aging cells behave like younger ones, a development that could open a new chapter in regenerative medicine. The ...
Background SIRT6 acts as a tumour suppressor in multiple cancers by regulating glucose and lipid metabolism, but its role in intrahepatic cholangiocarcinoma (ICC) remains unclear. Objective We ...